Paper11869080
Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees.
Wakitani S and 5 others. Osteoarthritis Cartilage, 2002. Cited by 683 papers, by iCite.
Cite this record
ConductScience Library. Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. Papers, record 11869080. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/11869080
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bone Marrow Transplantation | Major topic |
| Cartilage, Articular | Major topic |
| Osteoarthritis, Knee | Major topic |
| Regeneration | Major topic |
| Aged | |
| Case-Control Studies | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Transplantation, Autologous | |
| Treatment Outcome |
Source PubMed
Trials4
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01399749 | Autologous Mesenchymal Stem Cells vs. Chondrocytes for the Repair of Chondral Knee Defects | Background | ClinicalTrials.gov | |
| NCT01978639 | Injections of FloGraft Therapy, Autologous Stem Cells, or Platelet Rich Plasma for the Treatment of Degenerative Joint Pain | Background | ClinicalTrials.gov | |
| NCT04351932 | Bone Marrow Versus Adipose Autologous Mesenchymal Stem Cells for the Treatment of Knee Osteoarthritis | Results | ClinicalTrials.gov | |
| NCT05660824 | Effectiveness of Stromal Vascular Fraction (SVF) and Platelet -Rich Plasma (PRP) in Patients With Knee Osteoarthritis: Study Protocol for a Phase III, Prospective, Randomized, Controlled Multi-center Study. | Background | ClinicalTrials.gov |
Cited by316
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 683 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42796192 | Development of Microfluidic Culture System for Spatially Regulated Differentiation of Mesenchymal Stem Cells Toward Osteochondral Interface Regeneration. | Micromachines (Basel) | 2026 | https://conductscience.org/library/papers/42796192 | PubMed |
| 42791867 | Next-Generation Cartilage Repair: Clinical Use of Wharton's Jelly MSCs and the Emerging Role of AI-Assisted Bioprinting. | Bioengineering (Basel) | 2026 | https://conductscience.org/library/papers/42791867 | PubMed |
| 42125418 | Unveiling the potential use of bioprinting materials in directing stem cell fate for cartilage regeneration: Focusing on induced pluripotent stem cells and enhanced lubrication (Review). | Med Int (Lond) | 2026 | https://conductscience.org/library/papers/42125418 | PubMed |
| 41863718 | Efficacy and safety of intra-articular mesenchymal stem cell-based therapies in knee osteoarthritis: A systematic review and meta-analysis of randomized controlled trials. | Clin Rheumatol | 2026 | https://conductscience.org/library/papers/41863718 | PubMed |
| 41436713 | The Broken Cradle: Bone Marrow Stem Cell Niche Remodelling in Diabetes. | Stem Cell Rev Rep | 2026 | https://conductscience.org/library/papers/41436713 | PubMed |
| 41360821 | Deer antler ASCs exosomes ameliorate osteoarthritis via miR-140/MMP13 axis-mediated dual modulation of inflammation and cartilage regeneration. | NPJ Regen Med | 2025 | https://conductscience.org/library/papers/41360821 | PubMed |
| 41179515 | Long-Term Suppression of RUNX2 During MSC-Based Cartilage Formation Increases Cartilage Matrix Accumulation. | GEN Biotechnol | 2025 | https://conductscience.org/library/papers/41179515 | PubMed |
| 40977310 | Validation of a model of rheumatoid arthritis using mice reconstituted with patient peripheral blood mononuclear cells. | Dis Model Mech | 2025 | https://conductscience.org/library/papers/40977310 | PubMed |
| 40898279 | Validated methods for isolation and qualification of mesenchymal stromal/stem cells from different sources. | J Transl Med | 2025 | https://conductscience.org/library/papers/40898279 | PubMed |
| 40830968 | Engineered Extracellular Vesicles in Arthritic Diseases: Therapeutic Applications & Challenges. | Wiley Interdiscip Rev Nanomed Nanobiotechnol | 2025 | https://conductscience.org/library/papers/40830968 | PubMed |
| 40548002 | Bone Marrow Aspirate Concentrate Harvest and Delivery With a Neonatal Nasogastric Tube: A Simple Technique in Hip Arthroscopy. | Arthrosc Tech | 2025 | https://conductscience.org/library/papers/40548002 | PubMed |
| 40380984 | Evaluation of the Safety and Regenerative Potential of Human Mesenchymal Stem Cells and Their Extracellular Vesicles in a Transgenic Pig Model of Cartilage-Bone Injury In Vivo - Preclinical Study. | Stem Cell Rev Rep | 2025 | https://conductscience.org/library/papers/40380984 | PubMed |
| 40276361 | Molecular Aspects of Cartilage Microfracturation: Rehabilitation Insights. | Orthop Rev (Pavia) | 2025 | https://conductscience.org/library/papers/40276361 | PubMed |
| 40169165 | Stem cell injections for osteoarthritis of the knee. | Cochrane Database Syst Rev | 2025 | https://conductscience.org/library/papers/40169165 | PubMed |
| 40137363 | Treatment of Knee Osteoarthritis and Chondral Injury with Umbilical Cord/Wharton's Jelly-Derived Mesenchymal Stem Cells: A Systematic Review of Safety and Efficacy. | J Funct Biomater | 2025 | https://conductscience.org/library/papers/40137363 | PubMed |
| 39841308 | A Systematic Review and Meta-Analysis of Stem Cell Therapies for Pain in Diabetic Neuropathy, Osteoarthritis, and Spinal Cord Injuries. | Curr Pain Headache Rep | 2025 | https://conductscience.org/library/papers/39841308 | PubMed |
| 39822341 | Automated xeno-free chondrogenic differentiation from human embryonic stem cells: Enhancing efficiency and ensuring high-quality mass production. | Regen Ther | 2024 | https://conductscience.org/library/papers/39822341 | PubMed |
| 39795929 | Dual-Double Stem Cell Ovarian Therapy: A Comprehensive Approach in Regenerative Medicine. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39795929 | PubMed |
| 39558365 | Clinical outcomes of autologous adipose-derived mesenchymal stem cell combined with high tibial osteotomy for knee osteoarthritis are correlated with stem cell stemness and senescence. | J Transl Med | 2024 | https://conductscience.org/library/papers/39558365 | PubMed |
| 39452579 | Functional Scaffolds for Bone Tissue Regeneration: A Comprehensive Review of Materials, Methods, and Future Directions. | J Funct Biomater | 2024 | https://conductscience.org/library/papers/39452579 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/11869080
GET https://conductscience.org/api/papers/v1/11869080/cited_by?page=2